Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Large Decline in Short Interest

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) saw a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 1,710,000 shares, a decline of 34.5% from the May 15th total of 2,610,000 shares. Based on an average trading volume of 458,600 shares, the days-to-cover ratio is presently 3.7 days. Approximately 0.3% of the shares of the company are short sold.

Hedge Funds Weigh In On Fresenius Medical Care AG & Co. KGaA

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Wayfinding Financial LLC bought a new position in Fresenius Medical Care AG & Co. KGaA in the first quarter worth about $25,000. Spire Wealth Management bought a new stake in Fresenius Medical Care AG & Co. KGaA during the first quarter worth approximately $27,000. Smartleaf Asset Management LLC grew its position in Fresenius Medical Care AG & Co. KGaA by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after buying an additional 806 shares during the last quarter. Brooklyn Investment Group raised its position in shares of Fresenius Medical Care AG & Co. KGaA by 424.5% during the first quarter. Brooklyn Investment Group now owns 1,285 shares of the company's stock worth $32,000 after purchasing an additional 1,040 shares during the period. Finally, Russell Investments Group Ltd. lifted its stake in Fresenius Medical Care AG & Co. KGaA by 234.1% during the fourth quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company's stock valued at $71,000 after buying an additional 2,208 shares in the last quarter. 8.37% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on FMS shares. Wall Street Zen started coverage on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Tuesday, May 20th. They issued a "strong-buy" rating on the stock. Truist Financial lifted their target price on shares of Fresenius Medical Care AG & Co. KGaA from $25.00 to $30.00 and gave the stock a "hold" rating in a research note on Monday, May 12th. Finally, Morgan Stanley reiterated an "underweight" rating on shares of Fresenius Medical Care AG & Co. KGaA in a report on Thursday, May 15th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $27.80.

Fresenius Medical Care AG & Co. KGaA Trading Down 0.5%

Shares of FMS stock traded down $0.13 during midday trading on Friday, hitting $26.82. The company had a trading volume of 871,954 shares, compared to its average volume of 340,631. Fresenius Medical Care AG & Co. KGaA has a 52-week low of $17.93 and a 52-week high of $30.46. The company's 50 day simple moving average is $27.13 and its 200 day simple moving average is $24.86. The company has a current ratio of 1.46, a quick ratio of 1.08 and a debt-to-equity ratio of 0.40.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. The company had revenue of $5.54 billion for the quarter, compared to the consensus estimate of $4.71 billion. Fresenius Medical Care AG & Co. KGaA had a net margin of 3.18% and a return on equity of 6.25%. As a group, equities analysts anticipate that Fresenius Medical Care AG & Co. KGaA will post 1.51 earnings per share for the current year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The business also recently declared an annual dividend, which was paid on Friday, June 6th. Investors of record on Friday, May 23rd were given a dividend of $0.7871 per share. The ex-dividend date was Friday, May 23rd. This is a positive change from Fresenius Medical Care AG & Co. KGaA's previous annual dividend of $0.44. This represents a yield of 1.9%. Fresenius Medical Care AG & Co. KGaA's payout ratio is 50.89%.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.